Buckingham Strategic Partners »

Myriad Genetics shares owned by Buckingham Strategic Partners

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Buckingham Strategic Partners from 13F filings

Historical chart of Buckingham Strategic Partners investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Buckingham Strategic Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Buckingham Strategic Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $73k 12k 6.15
2025-09-30 $73k 11k 6.78

More positions owned by Buckingham Strategic Partners

Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ea Series Trust Ea Bridgeway Omn (BSVO)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Ishares Tr Core Msci Intl (IDEV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Us Mktwide Value (DFUV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Dimensional Etf Trust Us Equity Market (DFUS)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Dimensional Etf Trust World Ex Us Core (DFAX)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)

View all positions for Buckingham Strategic Partners

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
State Street Corporation
Millennium Management
Glenview Captal Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Geode Capital Management
Goldman Sachs Group
Charles Schwab Investment Management
AQR Capital Management
Federated Investors
Dimensional Fund Advisors
Point72 Asset Management
Vestal Point Capital

View all funds holding Myriad Genetics